Evidence map›Paper›PMID 27568890›Full record

Trial reportJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2016

The Effect of Supplemental Oxygen in Obesity Hypoventilation Syndrome.

Juan F Masa, Jaime Corral, Auxiliadora Romero, Candela Caballero, Joaquin Terán-Santos, Maria L Alonso-Álvarez, Teresa Gomez-Garcia, Mónica González, Soledad López-Martínez, Pilar De Lucas and 9 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01405976 (Mid-and Long-term Efficacy of Ventilation Non-invasive and Continuos Positive Airway Pressure in Obesity Hypoventilation Syndrome), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01405976 nacompletednot on this map

Mid-and Long-term Efficacy of Ventilation Non-invasive and Continuos Positive Airway Pressure in Obesity Hypoventilation Syndrome

TypeinterventionalSponsorSociedad Española de Neumología y Cirugía TorácicaRan2009 to 2017Enrolled440ConditionsObesity Hypoventilation SyndromeArmslife style modification, noninvasive ventilation, CPAP
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  3. Review
  4. Long-term oxygen therapy to reduce length of hospital stay in COVID-19.Revista da Associacao Medica Brasileira (1992) · 2024
    Article
  5. Article
  6. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  7. Article
  8. Observational
  9. [Highlights 57th SEPAR Congress].Open respiratory archives
    Review
  10. Article
  11. Obesity hypoventilation syndrome: a current review.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 2 countries.

Juan F MasaSan Pedro de Alcántara Hospital, Cáceres, Spain.
Jaime CorralSan Pedro de Alcántara Hospital, Cáceres, Spain.
Auxiliadora RomeroVirgen del Rocío Hospital, Sevilla, Spain.
Candela CaballeroVirgen del Rocío Hospital, Sevilla, Spain.
Joaquin Terán-SantosUniversity Hospital, Burgos, Spain.
Maria L Alonso-ÁlvarezUniversity Hospital, Burgos, Spain.
Teresa Gomez-GarciaIIS Fundación Jiménez Díaz, Madrid, Spain.
Mónica GonzálezValdecilla Hospital, Santander, Spain.
Soledad López-MartínezGregorio Marañon Hospital, Madrid, Spain.
Pilar De LucasGregorio Marañon Hospital, Madrid, Spain.
José M MarinMiguel Servet Hospital, Zaragoza, Spain.
Sergi MartiValld'Hebron Hospital, Barcelona, Spain.
Trinidad Díaz-CambrilesDoce de Octubre Hospital, Madrid, Spain.
Eusebi ChinerSan Juan Hospital, Alicante, Spain.
Miguel MerchanSan Pedro de Alcántara Hospital, Cáceres, Spain.
Carlos EgeaSleep Unit, Respiratory Department, Alava University Hospital IRB, Vitoria, Spain.
Ana ObesoDepartment of Physiology, University of Valladolid, Spain.
Babak MokhlesiDepartment of Medicine, Section of Pulmonary and Critical Care, University of Chicago, Chicago, IL.
Spanish Sleep Network
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital San Pedro de Alcántara · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Virgen del Rocío · ESHospital Universitario Araba · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitari Sant Joan D'Alacant · ESMarqués de Valdecilla University Hospital · ESUniversidad de Valladolid · ESUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesLow flow supplemental oxygen is commonly prescribed to patients with obesity hypoventilation syndrome (OHS). However, there is a paucity of data regarding its efficacy and safety. The objective of this study was to assess the medium-term treatment efficacy of adding supplemental oxygen therapy to commonly prescribed treatment modalities in OHS.

methodsIn this

resultsIn the noninvasive ventilation group, supplemental oxygen reduced systolic blood pressure although this could be also explained by a reduction in body weight experienced in this group. In the continuous positive airway pressure group, supplemental oxygen increased the frequency of morning confusion. In the lifestyle modification group, supplemental oxygen increased compensatory metabolic alkalosis and decreased the apnea-hypopnea index during sleep. Oxygen therapy was not associated with an increase in hospital resource utilization in any of the groups.

conclusionsAfter 2 mo of follow-up, chronic oxygen therapy produced marginal changes that were insufficient to consider it, globally, as beneficial or deleterious. Because supplemental oxygen therapy did not increase hospital resource utilization, we recommend prescribing oxygen therapy to patients with OHS who meet criteria with close monitoring. Long-term studies examining outcomes such as incident cardiovascular morbidity and mortality are necessary. CLINICAL TRIALS REGISTRATION: Clinicaltrial.gov, ID: NCT01405976.

Indexed as

AdolescentAdultAgedAged, 80 and overBlood Gas AnalysisBlood PressureFemaleFollow-Up StudiesHumansMaleMiddle AgedObesity Hypoventilation SyndromeOxygen Inhalation TherapyPolysomnographyQuality of LifeSpainnoninvasive ventilationobesity hypoventilation syndromeoxygen therapysleep apnea

Identifiers

PMID27568890
PMCPMC5033740
OpenAlexW2515919631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.